Telehealth Smoking Cessation for Quitting Smoking
(E-STOP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking cessation. Participants will be randomly assigned to receive either the smoking cessation e-visit or not. The e-visit will look similar to an online questionnaire asking about smoking history, motivation to quit, and preferences for medications for quitting smoking. Participants may receive a prescription for a smoking cessation medication as an outcome of the e-visit, if randomized to the e-visit group, but there is no requirement to take any medication. This study consists of questionnaires and breath samples provided at 4 separate time points throughout the study. Participation in this study will take about 24 weeks.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot have used an FDA-approved smoking cessation medication in the last 7 days before joining.
Is telehealth smoking cessation generally safe for humans?
How is the Telehealth Smoking Cessation treatment different from other smoking cessation treatments?
The Telehealth Smoking Cessation treatment is unique because it uses online and telehealth platforms to provide support, making it accessible for people who cannot attend in-person programs. This approach is particularly beneficial for individuals in rural or remote areas, offering a convenient and flexible alternative to traditional face-to-face or telephone-based support.34678
What data supports the effectiveness of the treatment Telehealth Smoking Cessation for Quitting Smoking?
Research shows that eHealth interventions, like online and telehealth programs, can effectively help people quit smoking by providing personalized support and resources. Internet-based programs have been found to be a promising alternative to traditional face-to-face methods, offering convenience and accessibility.49101112
Are You a Good Fit for This Trial?
This trial is for adults who smoke at least 5 cigarettes a day, are fluent in English, have daily email access, and own a smartphone. They must be enrolled or willing to enroll in MyChart with a valid address. It's not for those who've used FDA-approved quitting meds recently.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to receive either the smoking cessation e-visit or not, with e-visits including questionnaires and potential prescriptions for smoking cessation medication.
Follow-up
Participants are monitored for smoking cessation outcomes, including medication adoption, treatment utilization, and smoking reduction.
What Are the Treatments Tested in This Trial?
Interventions
- Smoking cessation e-visit
- Treatment As Usual
Smoking cessation e-visit is already approved in United States for the following indications:
- Smoking cessation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
National Cancer Institute (NCI)
Collaborator